PIPERACILLIN SODIUM and TAZOBACTAM SODIUM

Xellia Pharmaceuticals USA LLC🇺🇸 United States

FDA Page

Effective Date: Aug 26, 2022
Approval ID: 184b5961-1ae7-474c-afaa-2a2b2ccfc9cd
Products: 3 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PIPERACILLIN AND TAZOBACTAM FOR INJECTION safely and effectively. See full prescribing information for PIPERACILLIN AND TAZOBACTAM FOR INJECTION. PIPERACILLIN and TAZOBACTAM for injection, for intravenous use Initial U.S. Approval: 1993

Quick Stats

Total Products3

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.